← Leaderboards
Suzanne L. Walker
Harvard Medical School
$40,048,648
Attributed
$46,888,139
Total exposure
22
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$67,835,185 · 24
By mechanism
R01$29,325,939 · 8
U19$17,347,801 · 6
P01$16,830,801 · 5
T32$4,021,535 · 2
R21$169,500 · 1
R03$139,609 · 2
Top collaborators
- Daniel E Kahne12 shared
- Richard Marc Losick10 shared
- Frederick M Ausubel5 shared
- Thomas G Bernhardt5 shared
- Michael S. Gilmore5 shared
- David C Hooper5 shared
- Roberto G. Kolter5 shared
- Eleftherios Mylonakis5 shared
Most similar at Harvard Medical School
Same institution · by research overlap
- Thomas G Bernhardt$19,734,051
- David Z Rudner$19,646,254
- Andrew Kruse$16,257,686
- Anna I Weaver$221,404
- Rodrigo Fermin Ortiz-Meoz$101,404
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsResistanceInfectionAntibiotic ResistanceEnzymesStaphylococcus AureusAntibioticsBaseCellsProteinsPeptidoglycanProgramsGeneticLeadAnabolismInhibitor/AntagonistGenesStructureCell WallDesignTeichoic AcidsNovel StrategiesOrganismMutant
Grant awards (117)
Exploiting membrane targets to overcome antibiotic resistance$2,515,155
U19 · FY2025 · AI · contact PI
Discovery and characterization of new bacterial cell wall targets and inhibitors to treat resistant infections$801,392
R01 · FY2025 · AI · contact PI
Project 2: Targeting Gram-positive Cell Envelope Assembly$736,950
U19 · FY2025 · AI · contact PI
Subproject 1: Compounds and Pathways for Antibacterial Combinations$466,570
P01 · FY2025 · AI · contact PI
Administrative Core$130,562
U19 · FY2025 · AI · contact PI
Exploiting membrane targets to overcome antibiotic resistance$2,515,155
U19 · FY2024 · AI · contact PI
Discovery and characterization of new bacterial cell wall targets and inhibitors to treat resistant infections$767,231
R01 · FY2024 · AI · contact PI
Project 2: Targeting Gram-positive Cell Envelope Assembly$732,324
U19 · FY2024 · AI · contact PI
Defining OGT's Essential Functions to Guide Therapeutic Approaches$440,363
R01 · FY2024 · GM · contact PI
Subproject 1: Compounds and Pathways for Antibacterial Combinations$412,100
P01 · FY2024 · AI · contact PI
Exploiting membrane targets to overcome antibiotic resistance$168,043
U19 · FY2024 · AI · contact PI
Project 2: Targeting Gram-positive Cell Envelope Assembly$168,043
U19 · FY2024 · AI · contact PI
Administrative Core$131,322
U19 · FY2024 · AI · contact PI
Exploiting membrane targets to overcome antibiotic resistance$2,515,155
U19 · FY2023 · AI · contact PI
Discovery and characterization of new bacterial cell wall targets and inhibitors to treat resistant infections$767,231
R01 · FY2023 · AI · contact PI
Project 2: Targeting Gram-positive Cell Envelope Assembly$732,322
U19 · FY2023 · AI · contact PI
Defining OGT's Essential Functions to Guide Therapeutic Approaches$440,363
R01 · FY2023 · GM · contact PI
Subproject 1: Compounds and Pathways for Antibacterial Combinations$417,596
P01 · FY2023 · AI · contact PI
Administrative Core$131,325
U19 · FY2023 · AI · contact PI
Defining OGT's Essential Functions to Guide Therapeutic Approaches$77,717
R01 · FY2023 · GM · contact PI
Exploiting membrane targets to overcome antibiotic resistance$2,410,919
U19 · FY2022 · AI · contact PI
Discovery and characterization of new bacterial cell wall targets and inhibitors to treat resistant infections$767,231
R01 · FY2022 · AI · contact PI
Project 2: Targeting Gram-positive Cell Envelope Assembly$671,010
U19 · FY2022 · AI · contact PI
Release of Extracellular DNA during Biofilm Formation in Staphylococcus aureus$630,172
R01 · FY2022 · AI
Harvard Chemical Biology PhD Program$520,362
T32 · FY2022 · GM · contact PI
Defining OGT's Essential Functions to Guide Therapeutic Approaches$443,128
R01 · FY2022 · GM · contact PI
Subproject 1: Compounds and Pathways for Antibacterial Combinations$429,586
P01 · FY2022 · AI · contact PI
Administrative Core$167,091
U19 · FY2022 · AI · contact PI
Diversity Supplement: Defining OGT's Essential Functions to Guide Therapeutic Approaches$77,584
R01 · FY2022 · GM · contact PI
Discovery and characterization of new bacterial cell wall targets and inhibitors to treat resistant infections$767,231
R01 · FY2021 · AI · contact PI
Release of Extracellular DNA during Biofilm Formation in Staphylococcus aureus$630,172
R01 · FY2021 · AI
Defining OGT's Essential Functions to Guide Therapeutic Approaches$445,542
R01 · FY2021 · GM · contact PI
Defining OGT's Essential Functions to Guide Therapeutic Approaches - EQUIPMENT SUPPLEMENT$70,000
R01 · FY2021 · GM · contact PI
Discovery and characterization of new bacterial cell wall targets and inhibitors to treat resistant infections$767,231
R01 · FY2020 · AI · contact PI
Release of Extracellular DNA during Biofilm Formation in Staphylococcus aureus$630,172
R01 · FY2020 · AI
Harvard Chemical Biology Graduate Program$472,415
T32 · FY2020 · GM · contact PI
Subproject 1 Compounds and Strategies for Treating MRSA and VRE$467,649
P01 · FY2020 · AI · contact PI
Release of Extracellular DNA during Biofilm Formation in Staphylococcus aureus$630,172
R01 · FY2019 · AI
Harvard Chemical Biology Graduate Program$476,613
T32 · FY2019 · GM · contact PI
Subproject 1 Compounds and Strategies for Treating MRSA and VRE$468,315
P01 · FY2019 · AI · contact PI
Mechanism and Inhibition of Enzymes that Assemble Bacterial Cell Wall$444,819
R01 · FY2019 · GM · contact PI
Structure, Function and Inhibition of Human O-GlcNAc Transferase$433,587
R01 · FY2019 · GM · contact PI
Principles of Scientific Citizenship: Ethics, Communication, and Leadership for Scientists$86,400
T32 · FY2019 · GM · contact PI
Integrated Platform for the Discovery of Antibacterial$692,375
U19 · FY2018 · AI · contact PI
Release of Extracellular DNA during Biofilm Formation in Staphylococcus aureus$630,172
R01 · FY2018 · AI
Harvard Chemical Biology Graduate Program$471,299
T32 · FY2018 · GM · contact PI
Subproject 1 Compounds and Strategies for Treating MRSA and VRE$470,015
P01 · FY2018 · AI · contact PI
Mechanism and Inhibition of Enzymes that Assemble Bacterial Cell Wall$444,818
R01 · FY2018 · GM · contact PI
Structure, Function and Inhibition of Human O-GlcNAc Transferase$433,633
R01 · FY2018 · GM · contact PI
Integrated Platform for the Discovery of Antibacterial$731,405
U19 · FY2017 · AI · contact PI
Mechanism and Inhibition of Enzymes that Assemble Bacterial Cell Wall$444,819
R01 · FY2017 · GM · contact PI
Structure, Function and Inhibition of Human O-GlcNAc Transferase$429,423
R01 · FY2017 · GM · contact PI
Harvard Chemical Biology Graduate Program$372,892
T32 · FY2017 · GM · contact PI
Subproject 1 Compounds and Strategies for Treating MRSA and VRE$369,257
P01 · FY2017 · AI · contact PI
Identifying and validating new antibiotic targets in cell wall synthesis pathways$858,826
R01 · FY2016 · AI
Integrated Platform for the Discovery of Antibacterial$741,949
U19 · FY2016 · AI · contact PI
Subproject 1 Compounds and Strategies for Treating MRSA and VRE$548,430
P01 · FY2016 · AI · contact PI
Mechanism and Inhibition of Enzymes that Assemble Bacterial Cell Wall$476,268
R01 · FY2016 · GM · contact PI
Structure, Function and Inhibition of Human O-GlcNAc Transferase$429,423
R01 · FY2016 · GM · contact PI
Harvard Chemical Biology Graduate Program$322,743
T32 · FY2016 · GM · contact PI
Harvard-wide Program on Antibiotic Resistance$2,158,199
P01 · FY2015 · AI
Identifying and validating new antibiotic targets in cell wall synthesis pathways$858,826
R01 · FY2015 · AI
Integrated Platform for the Discovery of Antibacterial$731,560
U19 · FY2015 · AI · contact PI
Structure, Function and Inhibition of Human O-GlcNAc Transferase$517,469
R01 · FY2015 · GM · contact PI
Compound and Strategies for Treating MRSA and VRE$414,841
P01 · FY2015 · AI · contact PI
Harvard Chemical Biology Graduate Program$315,867
T32 · FY2015 · GM · contact PI
Enabling Biotechnologies to Generate Novel Phosphoglycolipid Antibiotics$38,831
R03 · FY2015 · TW · contact PI
Structure, Function and Inhibition of Human O-GlcNAc Transferase$27,523
R01 · FY2015 · GM · contact PI
Harvard-wide Program on Antibiotic Resistance$2,158,199
P01 · FY2014 · AI
Identifying and validating new antibiotic targets in cell wall synthesis pathways$858,826
R01 · FY2014 · AI
Integrated Platform for the Discovery of Antibacterial$725,136
U19 · FY2014 · AI · contact PI
Mechanism and Inhibition of Bacterial Transglycosylases and Transpeptidases.$533,887
R01 · FY2014 · GM · contact PI
Structure, Function and Inhibition of Human O-GlcNAc Transferase$517,469
R01 · FY2014 · GM · contact PI
Compound and Strategies for Treating MRSA and VRE$372,483
P01 · FY2014 · AI · contact PI
Harvard Chemical Biology Graduate Program$270,804
T32 · FY2014 · GM · contact PI
Enabling Biotechnologies to Generate Novel Phosphoglycolipid Antibiotics$38,831
R03 · FY2014 · TW · contact PI
Harvard-wide Program on Antibiotic Resistance$2,028,707
P01 · FY2013 · AI
Identifying and validating new antibiotic targets in cell wall synthesis pathways$807,102
R01 · FY2013 · AI
Mechanism and Inhibition of Bacterial Transglycosylases and Transpeptidases.$515,076
R01 · FY2013 · GM · contact PI
Structure, Function and Inhibition of Human O-GlcNAc Transferase$498,749
R01 · FY2013 · GM · contact PI
Compound and Strategies for Treating MRSA and VRE$350,134
P01 · FY2013 · AI · contact PI
Harvard Chemical Biology Graduate Program$267,927
T32 · FY2013 · GM · contact PI
Enabling Biotechnologies to Generate Novel Phosphoglycolipid Antibiotics$56,862
R03 · FY2013 · TW · contact PI
Harvard-wide Program on Antibiotic Resistance$2,310,720
P01 · FY2012 · AI
Identifying and validating new antibiotic targets in cell wall synthesis pathways$936,346
R01 · FY2012 · AI
Mechanism and Inhibition of Bacterial Transglycosylases and Transpeptidases.$532,332
R01 · FY2012 · GM · contact PI
Structure, Function and Inhibition of Human O-GlcNAc Transferase$530,282
R01 · FY2012 · GM · contact PI
Compound and Strategies for Treating MRSA and VRE$407,086
P01 · FY2012 · AI · contact PI
Harvard Chemical Biology Graduate Program$223,273
T32 · FY2012 · GM · contact PI
Harvard-wide Program on Antibiotic Resistance$2,166,794
P01 · FY2011 · AI
Mechanism and Inhibition of Bacterial Transglycosylases and Transpeptidases.$551,535
R01 · FY2011 · GM · contact PI
Compound and Strategies for Treating MRSA and VRE$414,120
P01 · FY2011 · AI · contact PI
Harvard Chemical Biology Graduate Program$220,940
T32 · FY2011 · GM · contact PI
Mechanism and Inhibition of Bacterial Transglycosylases$494,418
R01 · FY2010 · GM · contact PI
Wall Teichoic Acid Biosynthesis: A New Target for Therapeutic Intervention?$430,862
R01 · FY2010 · GM · contact PI
Mechanism and Inhibition of Bacterial Transglycosylases$483,478
R01 · FY2009 · GM · contact PI
Wall Teichoic Acid Biosynthesis: A New Target for Therapeutic Intervention?$427,159
R01 · FY2009 · GM · contact PI
Cell-based HTS for Compounds that Block Virulence Factor Expression in MRSA$169,500
R21 · FY2009 · NS · contact PI
Mechanism and Inhibition of Bacterial Transglycosylases$468,888
R01 · FY2008 · GM · contact PI
Wall Teichoic Acid Biosynthesis: A New Target for Therapeutic Intervention?$418,723
R01 · FY2008 · GM · contact PI
Mechanism and Inhibition of Bacterial Transglycosylases$495,657
R01 · FY2007 · GM · contact PI
Wall Teichoic Acid Biosynthesis: A New Target for Therapeutic Intervention?$422,813
R01 · FY2007 · GM · contact PI
Synthesis as a Tool to Understand Ramoplanin and Nisin$372,412
R01 · FY2006 · AI · contact PI
Structural and Mechanistic Studies on MurG$331,034
R01 · FY2006 · AI · contact PI
Synthesis as a Tool to Understand Ramoplanin and Nisin$381,375
R01 · FY2005 · AI
Structural and Mechanistic Studies on MurG$339,000
R01 · FY2005 · AI
Identification of O-Glc NAc Transferase Inhibitors(RMI)$5,085
R03 · FY2005 · MH
Structural and Mechanistic Studies on MurG$250,992
R01 · FY2004 · AI
Synthesis as a Tool to Understand Ramoplanin and Nisin$175,268
R01 · FY2004 · AI
Synthesis as a Tool to Understand Ramoplanin and Nisin$163,229
R01 · FY2004 · AI
Structural and Mechanistic Studies on MurG$56,655
R01 · FY2004 · AI
Synthesis as a Tool to Understand Ramoplanin and Nisin$340,722
R01 · FY2003 · AI
Structural and Mechanistic Studies on MurG$293,524
R01 · FY2003 · AI
Synthesis as a Tool to Understand Ramoplanin and Nisin$358,344
R01 · FY2002 · AI
Structural and Mechanistic Studies on MurG$282,442
R01 · FY2002 · AI
SYNTHESIS AND EVALUATION OF MURG SUBSTRATE ANALOGS$240,909
R01 · FY2001 · AI
SYNTHESIS AND EVALUATION OF MURG SUBSTRATE ANALOGS$233,893
R01 · FY2000 · AI